Patent · US Active

Administration of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthoic acid for the treatment of dermatological disorders

US8703820B2 · kind B2 · utility

6Cited by

12References

20Claims

0Family size

Assignee

GALDERMA RESEARCH & DEVELOPMENT · FR

Inventors

Michael Graeber · Berlin, DE
Janusz Czernielewski · Montargis, FR

Key dates

Filing date	Oct 12, 2010
Grant date	Apr 22, 2014
Priority date	—
Expiry date	Dec 2, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2603/74
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Dermatological disorders having an inflammatory or proliferative component are treated with pharmaceutical compositions containing on the order of 0.3% by weight of 6-[3-(1-adamantyl)-4-methoxyphenyl]-2-naphthanoic acid (adapalene) or salt thereof, formulated into pharmaceutically acceptable media therefor, advantageously topically applicable gels, creams or lotions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.